With private equity firms facing increased scrutiny by various government agencies, the insight and guidance of antitrust counsel is more important than ever before. Sitting on the hot seat, any PE transaction is at risk of drawing regulatory attention and being classified as a perceived threat to competition.
You are invited to join highly experienced members of our Antitrust practice for an important discussion on how private equity firms and their portfolio companies can navigate the current regulatory environment and avoid becoming a target in this heated climate.
Key topics include:
Increased scrutiny of PE deals on both sides of the Atlantic (“Roll-ups” and prior approval provisions)
FTC proposed ban on non-compete agreements
Information sharing risk
Antitrust - civil and criminal enforcement updates
Sponsor liability for illegal conduct of portfolio companies
Megan Gerking –Antitrust Partner and former trial attorney with the DOJ’s Antitrust Division.
Jeff Jaeckel – Antitrust Partner and Vice Chair of the firm, with a focus on strategy and structuring of transactions to avoid antitrust risk.
Alex Okuliar – Co-chair of the Global Antitrust Law Practice and former Deputy Assistant Attorney General overseeing merger reviews and civil enforcement in the DOJ Antitrust Division and former FTC official.
Lisa Phelan – Co-chair of the Global Antitrust Law Practice and former Chief of the National Criminal Enforcement and Washington Criminal I Sections of the DOJ Antitrust Division.
Marie-Claire Strawbridge – Antitrust Partner with extensive experience in UK/EU merger control and national security reviews in the UK.